Further corroborating our results, lnc-RNFT2-1 and lnc-CLVS1-1, identified as lncRNAs uniquely differentially expressed in the L-blast fraction, have previously been shown to be differentially expressed in CD34+ hematopoietic stem and progenitor cells of patients with MDS compared to healthy donors through micro-array profiling by Liu and colleagues [23]. The gene discussed is CD34; the disease is myelodysplastic syndrome.